I'd ask your gastroenterologist. I took a look this afternoon, and came up with the following for uc patients. From what I understand, a loss of response is often defined as a remicade/infliximab serum trough (minimum) concentration of 0.8 μg/mL or less , and also a high concentration of infliximab antibodies, which is 10 U/mL or more.
For comparison, a good or high infliximab trough concentration is defined as greater than 5.0 mg/L. Good antibody concentration is ideally zero, but lower than 10 U/mL is fine.
"Low infliximab concentrations (median trough level, 0 μg/mL) and high anti-infliximab antibody concentrations (median trough level, 85 U/mL) were associated with a loss of response (P=.0083 and P=.0007 for association of infliximab and anti-infliximab antibody trough levels, respectively).
The cutoff values for infliximab and anti-infliximab antibody trough levels were also determined for UC patients: 0.8 μg/mL for infliximab (75% sensitivity [95% CI, 35-97] and 100% specificity [95% CI, 48–100]) and 10 U/mL for anti-infliximab antibodies (80% sensitivity [95% CI, 44–97] and 100% specificity [95% CI, 69–100])."
Source:
www.ncbi.nlm.nih.gov/pmc/articles/PMC3317512/